Stockscreener 앱 받기
199.60
2.46%
4.789
시간 외 거래:
199.60
-0.0028
-0.00%
전일 마감가:
$194.81
열려 있는:
$198.02
하루 거래량:
16,277
Relative Volume:
1.98
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+5.46%
1개월 성능:
+2.57%
6개월 성능:
+28.21%
1년 성능:
+24.17%
1일 변동 폭
$198.00
$200.00
1주일 범위
$187.38
$200.00
52주 변동 폭
$135.34
$200.00
Vaneck Biotech Etf Stock (BBH) Company Profile
BBH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBH
Vaneck Biotech Etf
|
199.60 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
340.05 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
689.58 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
692.63 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
267.47 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
624.02 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Biotech Etf 주식(BBH)의 최신 뉴스
As Gold Soars, Opportunity Lies in ‘Better, Not Bigger’ Mining Acquisitions - VanEck
Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Decreases By 16.5% - Defense World
How to Buy Gilead Sciences Stock (GILD) - The Motley Fool
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge (NASDAQ:BIIB) - Seeking Alpha
VanEck Biotech ETF declares annual distribution of $0.9565 - MSN
3 ASX ETFs to target in the new year – the booming themes of 2025 - The Motley Fool Australia
Day by day downgrades VanEck ETF TrustVanEck Biotech ETF (BBH) - MSN
Can Amgen Sustain Its Rally In 2026 (NASDAQ:AMGN) - Seeking Alpha
Why Are Investors Re-Evaluating Large Pharmaceutical Companies? - VanEck
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Sahm
VanEck Mid-December 2025 Bitcoin ChainCheck - VanEck
VanEck Announces Year-End Distributions for VanEck Equity ETFs - Crypto Reporter
VanEck ETF TrustVanEck Biotech ETF announces Annual dividend, payable on December 26, 2025 - marketscreener.com
5 Best ETFs for Tax-Loss Harvesting | Investing | U.S. News - US News Money
November Market Recap: AI Adoption Surges & Tight Liquidity Creates Opportunity - VanEck
The Fed cut interest rates and bought short-term bonds, Powell leaned dovish, US stocks, short-term US bonds, and gold rose, the dollar fell, while Bitcoin fluctuated. - 富途牛牛
Biotech may still have life - Investment Executive
EDGAR Filing Documents for 0000930413-25-003577 - SEC.gov
How Much More Tightening in EM? - VanEck
Inflation Persistence in EM - VanEck
Chinese Bonds Offer Yield Pickup - VanEck
AI Revolutionizes Pharma and Biotech Sectors: Market Trends for 2025 - Blockchain News
EM High Yield Corporates: Superior Yields, Low Defaults - VanEck
How India’s Digital Economy Compares to China - VanEck
InflationDownside Surprises Stage Comeback - VanEck
Higher for LongerMarket Not So Sure - VanEck
Global Pressures – Pick a Direction - VanEck
AI in Pharma and Biotech: Market Trends 2025 and Beyond - VanEck
AI In Pharma And Biotech: Market Trends 2025 And Beyond - Seeking Alpha
China – Lockdowns, Growth, Policy Options - VanEck
Sentiment Swings and Fundamentals - VanEck
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - The AI Journal
Diversify Your Portfolio: These 5 AI ETFs Could Surge 200% by 2030 - Nasdaq
Rates and Consequences - VanEck
Gold Responds and Reminds in March - VanEck
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Uncover Big Opportunities in Smaller Companies - VanEck
The Future of Fandom: Why Esports and Gaming Are Outpacing Traditional Sports - VanEck
Investing in Semiconductor ETFs & Stocks - VanEck
SMH ETF: Question & Answer - VanEck
Boston Research & Management Inc. Lowers Stock Holdings in VanEck Biotech ETF $BBH - Defense World
S&P 500: Health Care Stocks Come Alive — Nudging Tech Aside For Now - Investor's Business Daily
VanEck Mid-November 2025 Bitcoin ChainCheck - VanEck
Top Blockchain Companies to Watch Leading into 2026 - VanEck
Three Factors Driving Bitcoin’s Price - VanEck
VanEck Vectors Biotech ETF (BBHus) Stock Price Quote Today & Current Price Chart - Capital.com
A Potential Valuation Methodology for Ethereum - VanEck
VanEck Europe: Celebrating 30 Billion USD in AUM, 70 Years of Innovation, and 10 Years Listed on Deutsche Börse - VanEck
Big Pharma rally as FDA picks new drug regulator (LLY:NYSE) - Seeking Alpha
Rare Earths in the Spotlight as US and China Battle Over Supply - VanEck
Gold in 2025: A New Era of Structural Strength and Enduring Appeal - VanEck
Vaneck Biotech Etf (BBH) 재무 분석
Vaneck Biotech Etf (BBH)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.16%
0.26%
자본화:
|
볼륨(24시간):